IT1186772B
(it)
*
|
1985-10-10 |
1987-12-16 |
Crinos Industria Farmaco |
Composto ad attivita' pilostimolante
|
CA1291123C
(en)
*
|
1986-03-14 |
1991-10-22 |
Abraham Nimrod |
Heavy metal salts of hyaluronic acid useful as antimicrobial agents
|
US5668116A
(en)
*
|
1987-03-19 |
1997-09-16 |
Anthropharm Pty. Limited |
Anti-inflammatory compounds and compositions
|
WO1988007060A1
(en)
*
|
1987-03-19 |
1988-09-22 |
Arthropharm Pty. Limited |
Anti-inflammatory compounds and compositions
|
EP0292220B1
(en)
*
|
1987-05-20 |
1991-08-14 |
Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo |
Condom
|
IL86933A
(en)
*
|
1987-07-01 |
1993-07-08 |
Genentech Inc |
Method and therapeutic compositions for the prevention of fibrin deposition for adhesions
|
US5055298A
(en)
*
|
1987-12-01 |
1991-10-08 |
Chemisches Laboratorium Dr. Kurt Richter Gmbh |
Cosmetic composition comprising an extracellular connective tissue matrix
|
JPH01213227A
(ja)
*
|
1988-02-23 |
1989-08-28 |
Tadashi Koyake |
軟膏剤及び液剤
|
IT1219587B
(it)
*
|
1988-05-13 |
1990-05-18 |
Fidia Farmaceutici |
Polisaccaridi carbossiilici autoreticolati
|
US4981955A
(en)
*
|
1988-06-28 |
1991-01-01 |
Lopez Lorenzo L |
Depolymerization method of heparin
|
JPH0232013A
(ja)
*
|
1988-07-20 |
1990-02-01 |
Denki Kagaku Kogyo Kk |
点鼻剤
|
JPH02200624A
(ja)
*
|
1989-01-30 |
1990-08-08 |
Nippon Kayaku Co Ltd |
歯科用包帯剤
|
HU203372B
(en)
|
1989-02-24 |
1991-07-29 |
Richter Gedeon Vegyeszet |
Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
|
US6458774B1
(en)
*
|
1989-02-24 |
2002-10-01 |
Richter Gedeon Vegyeszeti Gyar Rt. |
Compositions containing hyaluronic acid associates and a process for preparing same
|
US5472950A
(en)
*
|
1989-02-24 |
1995-12-05 |
Richter Gedeon Vegyeszeti Gyar Rt. |
Compositions containing cobalt hyaluronic acid complex
|
CA1340994C
(en)
*
|
1989-09-21 |
2000-05-16 |
Rudolf Edgar Dr. Falk |
Treatment of conditions and disease
|
JP2945993B2
(ja)
*
|
1989-12-05 |
1999-09-06 |
武田薬品工業株式会社 |
外用剤
|
US5141928B1
(en)
*
|
1989-12-20 |
1995-11-14 |
Brujo Inc |
Ophthalmic medication
|
NL8903155A
(nl)
*
|
1989-12-23 |
1991-07-16 |
Stamicarbon |
Harssamenstelling op basis van een polyesterhars, een aminohars en een epoxyhars.
|
ES2146200T3
(es)
*
|
1990-02-13 |
2000-08-01 |
Ethicon Inc |
Medicamentos inducidos peritonealmente.
|
IT1240316B
(it)
*
|
1990-02-21 |
1993-12-07 |
Ricerca Di Schiena Del Dr. Michele G. Di Schiema & C. |
Composizioni a base di acido ialuronico ad alto peso molecolare somministrabili per via topica per il trattamento di infiammazioni del cavo orale ,per la cosmetica e l'igiene del cavo orale
|
US5639738A
(en)
*
|
1992-02-20 |
1997-06-17 |
Hyal Pharmaceutical Corporation |
Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
|
CA2061566C
(en)
*
|
1992-02-20 |
2002-07-09 |
Rudolf E. Falk |
Treatment of disease employing hyaluronic acid and nsaids
|
US5910489A
(en)
*
|
1990-09-18 |
1999-06-08 |
Hyal Pharmaceutical Corporation |
Topical composition containing hyaluronic acid and NSAIDS
|
US5990096A
(en)
*
|
1990-09-18 |
1999-11-23 |
Hyal Pharmaceutical Corporation |
Formulations containing hyaluronic acid
|
US5824658A
(en)
*
|
1990-09-18 |
1998-10-20 |
Hyal Pharmaceutical Corporation |
Topical composition containing hyaluronic acid and NSAIDS
|
CA2061703C
(en)
*
|
1992-02-20 |
2002-07-02 |
Rudolf E. Falk |
Formulations containing hyaluronic acid
|
IT1243435B
(it)
*
|
1990-10-05 |
1994-06-10 |
Altergon Sa |
Composizioni farmaceutiche per uso topico comprendenti acido ialuronico sale sodico e sostanze disinfettanti
|
US5492936A
(en)
*
|
1990-11-30 |
1996-02-20 |
Allergan, Inc. |
Bimodal molecular weight hyaluronate formulations and methods for using same
|
US5234914A
(en)
*
|
1991-06-11 |
1993-08-10 |
Patent Biopharmaceutics, Inc. |
Methods of treating hemorrhoids and anorecial disease
|
WO1994007505A1
(en)
*
|
1991-07-03 |
1994-04-14 |
Norpharmco Inc. |
Use of hyaluronic acid and forms to prevent arterial restenosis
|
US5977088A
(en)
*
|
1991-07-03 |
1999-11-02 |
Hyal Pharmaceutical Corporation |
Formulations containing hyaluronic acid
|
US5834444A
(en)
*
|
1991-07-03 |
1998-11-10 |
Hyal Pharmaceutical Corporation |
Hyaluronic acid and salts thereof inhibit arterial restenosis
|
US6022866A
(en)
*
|
1991-07-03 |
2000-02-08 |
Hyal Pharmaceutical Corporation |
Use of hyaluronic acid and forms to prevent arterial restenosis
|
US5792753A
(en)
*
|
1991-07-03 |
1998-08-11 |
Hyal Pharmaceutical Corporation |
Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
|
US6103704A
(en)
*
|
1991-07-03 |
2000-08-15 |
Hyal Pharmaceutical Corporation |
Therapeutic methods using hyaluronic acid
|
US5817644A
(en)
*
|
1991-07-03 |
1998-10-06 |
Hyal Pharmaceutical Corporation |
Targeting of dosages of medicine and therapeutic agents
|
US5990095A
(en)
|
1991-07-03 |
1999-11-23 |
Hyal Pharmaceutical Corporation |
Use of hyaluronic acid and forms to prevent arterial restenosis
|
CA2129238A1
(en)
*
|
1992-02-10 |
1993-08-19 |
F. Richard Christ |
Bimodal molecular weight hyaluronate formulations and methods for using same
|
CA2061567C
(en)
*
|
1992-02-20 |
1998-02-03 |
Rudolf E. Falk |
Use of hyaluronic acid to repair ischemia reperfusion damage
|
US6218373B1
(en)
|
1992-02-20 |
2001-04-17 |
Hyal Pharmaceutical Corporation |
Formulations containing hyaluronic acid
|
US6136793A
(en)
*
|
1992-02-20 |
2000-10-24 |
Hyal Pharmaceutical Corporation |
Formulations containing hyaluronic acid
|
US5767106A
(en)
*
|
1992-02-21 |
1998-06-16 |
Hyal Pharmaceutical Corporation |
Treatment of disease and conditions associated with macrophage infiltration
|
US6114314A
(en)
*
|
1992-02-21 |
2000-09-05 |
Hyal Pharmaceutical Corp. |
Formulations containing hyaluronic acid
|
CA2130762C
(en)
*
|
1994-08-24 |
1999-07-06 |
Eva Anne Turley |
Treatment of disease and conditions associated with macrophage infiltration
|
ES2079994B1
(es)
*
|
1992-10-07 |
1996-08-01 |
Cusi Lab |
Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.
|
IT1263144B
(it)
*
|
1993-02-04 |
1996-08-01 |
Lanfranco Callegaro |
Composizioni farmaceutiche comprendenti materiale spugnoso costituito da derivati esterei dell'acido ialuronico in associazione con altre sostanze farmacologicamente attive
|
AU5643994A
(en)
*
|
1993-03-04 |
1994-09-08 |
Genzyme Limited |
Controlled molecular weight reduction of polymers
|
US5616568A
(en)
*
|
1993-11-30 |
1997-04-01 |
The Research Foundation Of State University Of New York |
Functionalized derivatives of hyaluronic acid
|
JP4010574B2
(ja)
*
|
1994-12-05 |
2007-11-21 |
電気化学工業株式会社 |
皮膚外用剤
|
US5972326A
(en)
*
|
1995-04-18 |
1999-10-26 |
Galin; Miles A. |
Controlled release of pharmaceuticals in the anterior chamber of the eye
|
CA2154103C
(en)
*
|
1995-07-18 |
1998-02-24 |
Samuel Simon Asculai |
Treatment of mucous membrane disease, trauma or condition and for the relief of pain
|
ZA966579B
(en)
*
|
1995-08-04 |
1998-02-02 |
Wakamoto Pharma Co Ltd |
O/W emulsion composition for eye drops.
|
IT1287227B1
(it)
*
|
1996-04-04 |
1998-08-04 |
Fidia Spa In Amministrazione S |
Acido ialuronico quale componente del liquido di conservazione della cornea
|
US5939047A
(en)
*
|
1996-04-16 |
1999-08-17 |
Jernberg; Gary R. |
Local delivery of chemotherapeutic agents for treatment of periodontal disease
|
US6451326B2
(en)
|
1996-05-02 |
2002-09-17 |
Burt D. Ensley |
Cosmetic compositions
|
HU225991B1
(en)
*
|
1997-04-29 |
2008-02-28 |
Richter Gedeon Nyrt |
Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer
|
IT1287967B1
(it)
*
|
1996-10-17 |
1998-09-10 |
Fidia Spa In Amministrazione S |
Preparazioni farmaceutiche per uso anestetico locale
|
US5843186A
(en)
*
|
1996-12-20 |
1998-12-01 |
Implemed, Inc. |
Intraocular lens with antimicrobial activity
|
US5789571A
(en)
*
|
1997-01-15 |
1998-08-04 |
Biocoat Incorporated |
Method of making free acids from polysaccharide salts
|
US20050090662A1
(en)
*
|
1997-01-15 |
2005-04-28 |
Beavers Ellington M. |
Method of making free acids from polysaccharide salts
|
US6294170B1
(en)
|
1997-08-08 |
2001-09-25 |
Amgen Inc. |
Composition and method for treating inflammatory diseases
|
EP0971961B1
(en)
*
|
1997-04-04 |
2002-12-04 |
Fidia Advanced Biopolymers S.R.L. |
N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation
|
US6123957A
(en)
*
|
1997-07-16 |
2000-09-26 |
Jernberg; Gary R. |
Delivery of agents and method for regeneration of periodontal tissues
|
DE69833665T2
(de)
*
|
1997-08-08 |
2006-11-09 |
Duke University |
Zusammensetzungen zur vereinfachung von chirurgischen verfahren
|
US6711436B1
(en)
|
1997-08-08 |
2004-03-23 |
Duke University |
Compositions, apparatus and methods for facilitating surgical procedures
|
US6514983B1
(en)
|
1997-09-03 |
2003-02-04 |
Guilford Pharmaceuticals Inc. |
Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
|
US6346536B1
(en)
|
1997-09-03 |
2002-02-12 |
Guilford Pharmaceuticals Inc. |
Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
|
US6635642B1
(en)
|
1997-09-03 |
2003-10-21 |
Guilford Pharmaceuticals Inc. |
PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
|
US6426415B1
(en)
|
1997-09-03 |
2002-07-30 |
Guilford Pharmaceuticals Inc. |
Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
|
US6291425B1
(en)
|
1999-09-01 |
2001-09-18 |
Guilford Pharmaceuticals Inc. |
Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
|
US6197785B1
(en)
|
1997-09-03 |
2001-03-06 |
Guilford Pharmaceuticals Inc. |
Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
|
US6391336B1
(en)
|
1997-09-22 |
2002-05-21 |
Royer Biomedical, Inc. |
Inorganic-polymer complexes for the controlled release of compounds including medicinals
|
US6395749B1
(en)
|
1998-05-15 |
2002-05-28 |
Guilford Pharmaceuticals Inc. |
Carboxamide compounds, methods, and compositions for inhibiting PARP activity
|
JP2002193830A
(ja)
*
|
1998-10-19 |
2002-07-10 |
High Chem Co Ltd |
経鼻投与用医薬製剤
|
DK172900B1
(da)
*
|
1998-12-18 |
1999-09-27 |
Per Julius Nielsen |
Præparat samt kit til brug ved intraoculære operationer
|
US6387902B1
(en)
|
1998-12-31 |
2002-05-14 |
Guilford Pharmaceuticals, Inc. |
Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
|
JP4790911B2
(ja)
|
1999-01-13 |
2011-10-12 |
アルケミア オンコロジー ピーティワイ リミテッド |
薬物の効力を増強するための組成物および方法
|
WO2000044367A2
(en)
*
|
1999-02-01 |
2000-08-03 |
Dermal Research Laboratories, Inc. |
A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
|
WO2001090077A1
(en)
|
2000-05-19 |
2001-11-29 |
Guilford Pharmaceuticals, Inc. |
Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses
|
WO2001091796A2
(en)
|
2000-06-01 |
2001-12-06 |
Guilford Pharmaceuticals Inc. |
Methods, compounds and compositions for treating gout
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
AUPQ879500A0
(en)
*
|
2000-07-14 |
2000-08-10 |
Meditech Research Limited |
Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
|
US9066919B2
(en)
*
|
2000-07-14 |
2015-06-30 |
Alchemia Oncology Pty Limited |
Hyaluronan as a chemo-sensitizer in the treatment of cancer
|
US6828308B2
(en)
*
|
2000-07-28 |
2004-12-07 |
Sinclair Pharmaceuticals, Ltd. |
Compositions and methods for the treatment or prevention of inflammation
|
US7879824B2
(en)
*
|
2001-07-31 |
2011-02-01 |
Dermal Research Laboratories, Inc. |
Methods of preventing or treating diseases and conditions using complex carbohydrates
|
US6576226B1
(en)
|
2000-11-17 |
2003-06-10 |
Gary R. Jernberg |
Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
|
US6726898B2
(en)
|
2000-11-17 |
2004-04-27 |
Gary R. Jernberg |
Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
|
ES2250504T3
(es)
|
2000-11-29 |
2006-04-16 |
Allergan Inc. |
Prevencion del rechazo de injerto en el ojo.
|
ITMI20010708A1
(it)
*
|
2001-04-03 |
2002-10-03 |
Alessandro Randazzo |
Trattamento farmacologico degli aloni notturni e delle immagini fantasma con parasimpaticomimetici diluiti aceclidina/pilocarpina dopo inter
|
AR034371A1
(es)
*
|
2001-06-08 |
2004-02-18 |
Novartis Ag |
Composiciones farmaceuticas
|
CA2458856C
(en)
*
|
2001-08-27 |
2011-02-15 |
Meditech Research Limited |
Improved therapeutic protocols
|
ES2282469T3
(es)
*
|
2001-09-19 |
2007-10-16 |
Nycomed Gmbh |
Combinacion de un nsaid y un inhibidor de pde-4.
|
ITMI20021666A1
(it)
*
|
2002-07-26 |
2004-01-26 |
Jasper Ltd Liability Co |
Derivati dell'acido ialuronico
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
WO2005016386A1
(en)
*
|
2003-08-19 |
2005-02-24 |
Meditech Research Limited |
Improved therapeutic protocols
|
US20050043251A1
(en)
*
|
2003-08-20 |
2005-02-24 |
Fairfield Clinical Trials, Llc |
Method of treatment of otitis externa
|
US20050101582A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
US20070224278A1
(en)
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
US7625581B2
(en)
*
|
2003-12-19 |
2009-12-01 |
Ethicon, Inc. |
Tissue scaffolds for use in muscoloskeletal repairs
|
US20050147570A1
(en)
*
|
2004-01-06 |
2005-07-07 |
Nordsiek Michael T. |
Methods of administering diclofenac compositions for treating photodamaged skin, rosacea and/or acne
|
EP1706095B1
(en)
|
2004-01-20 |
2008-12-24 |
Allergan, Inc. |
Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
|
FR2865651B1
(fr)
|
2004-01-29 |
2007-09-28 |
Fabre Pierre Dermo Cosmetique |
Compositions topiques associant des fragments de hyaluronate de sodium et un retinoide utiles en dermatologie cosmetique et medicale
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
US8147865B2
(en)
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US8119154B2
(en)
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
GB0416397D0
(en)
*
|
2004-07-22 |
2004-08-25 |
Glaxo Group Ltd |
Pharmaceutical formulations
|
SE0402272D0
(sv)
|
2004-09-21 |
2004-09-21 |
Amo Groningen Bv |
Methods of treating a body site with a viscoelastic preparation
|
AU2005286682B2
(en)
*
|
2004-09-21 |
2011-06-23 |
Amo Groningen, B.V. |
Viscoelastic solution or gel formulation, and methods of treating a body site with the same
|
EP1721602A1
(en)
*
|
2005-05-11 |
2006-11-15 |
The Jordanian Pharmaceutical Manufacturing Co. |
Controlled release oral drug delivery system
|
FR2888752B1
(fr)
*
|
2005-07-22 |
2007-10-05 |
Fabre Pierre Dermo Cosmetique |
Complexe d'association intermoleculaire d'un transporteur et d'un principe actif
|
WO2007012133A1
(en)
*
|
2005-07-27 |
2007-02-01 |
Alchemia Oncology Pty Limited |
Therapeutic protocols using hyaluronan
|
EP1922077A4
(en)
*
|
2005-09-07 |
2013-03-06 |
Alchemia Oncology Pty Ltd |
THERAPEUTIC COMPOSITIONS WITH HYALURON AND THERAPEUTIC ANTIBODIES AND TREATMENT PROCEDURES
|
US20070065515A1
(en)
*
|
2005-09-22 |
2007-03-22 |
Key Douglas J |
Methods and compositions for treating skin lines and wrinkles and improving skin quality
|
JP4555232B2
(ja)
*
|
2006-01-25 |
2010-09-29 |
Hoya株式会社 |
組織の蛍光染色方法
|
US8668676B2
(en)
|
2006-06-19 |
2014-03-11 |
Allergan, Inc. |
Apparatus and methods for implanting particulate ocular implants
|
US8802128B2
(en)
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
EP2037874A1
(en)
*
|
2006-06-28 |
2009-03-25 |
Novozymes Biopolymer A/S |
Compositions with several hyaluronic acid fractions for cosmetic and medical uses
|
WO2008003321A2
(en)
*
|
2006-07-07 |
2008-01-10 |
Novozymes Biopolymer A/S |
Compositions with several hyaluronic acid fractions for cosmetic use
|
US9039761B2
(en)
|
2006-08-04 |
2015-05-26 |
Allergan, Inc. |
Ocular implant delivery assemblies with distal caps
|
AU2007295894B2
(en)
|
2006-09-13 |
2013-10-17 |
Enhance Skin Products, Inc. |
Cosmetic composition for the treatment of skin and methods thereof
|
WO2008094910A2
(en)
|
2007-01-30 |
2008-08-07 |
Cypress Pharmaceutical, Inc. |
Hyaluronate compositions
|
US20090068122A1
(en)
*
|
2007-09-06 |
2009-03-12 |
Shira Pilch |
Dentifrice Compositions for Treating Xerostomia
|
MX2010005331A
(es)
|
2007-11-16 |
2010-08-11 |
Vicept Therapeutics Inc |
Composiciones y metodos para tratamiento de purpura.
|
EP2288355A1
(en)
*
|
2008-05-30 |
2011-03-02 |
Fairfield Clinical Trials LLC |
Method and composition for skin inflammation and discoloration
|
WO2010003797A1
(en)
*
|
2008-07-09 |
2010-01-14 |
Novozymes Biopharma Dk A/S |
Hyaluronic acid for corneal wound healing
|
CN102223858B
(zh)
|
2008-10-02 |
2015-04-01 |
L.R.R.&D.有限公司 |
界面层伤口敷料
|
CN101385874B
(zh)
*
|
2008-10-23 |
2012-11-28 |
武汉大学 |
一种含有高分子透明质酸的生物滑液的制备方法
|
US8545554B2
(en)
|
2009-01-16 |
2013-10-01 |
Allergan, Inc. |
Intraocular injector
|
JP2012526819A
(ja)
*
|
2009-05-11 |
2012-11-01 |
イッサム リサーチ ディベロプメント カンパニー オブ ザ ヘブリュー ユニバーシティ オブ エルサレム リミテッド |
脂質−ポリマー複合体、その調製、及びその使用
|
TWI516269B
(zh)
|
2009-08-14 |
2016-01-11 |
禾伸堂生技股份有限公司 |
使用於炎症性腸疾病(ibd)治療和預防之透明質酸混合物
|
TWI383796B
(zh)
|
2009-08-14 |
2013-02-01 |
Holy Stone Healthcare Co Ltd |
Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
|
US8575130B2
(en)
|
2010-01-04 |
2013-11-05 |
Holy Stone Healthcare Co., Ltd. |
Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
|
US8722644B2
(en)
|
2010-01-04 |
2014-05-13 |
Holy Stone Healthcare Co., Ltd. |
Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
|
US9114188B2
(en)
|
2010-01-13 |
2015-08-25 |
Allergan, Industrie, S.A.S. |
Stable hydrogel compositions including additives
|
US20110172180A1
(en)
|
2010-01-13 |
2011-07-14 |
Allergan Industrie. Sas |
Heat stable hyaluronic acid compositions for dermatological use
|
US9029347B2
(en)
|
2010-08-05 |
2015-05-12 |
Holy Stone Healthcare Co., Ltd. |
Method and mixture for treating and preventing inflammatory bowel disease
|
IT1407283B1
(it)
*
|
2010-12-06 |
2014-04-04 |
Paoli Ambrosi De |
Nuovo composto di carnosina
|
CZ303548B6
(cs)
|
2011-01-05 |
2012-11-28 |
Contipro Pharma A.S. |
Zdravotní prípravek tvorící jód, zpusob jeho prípravy a bandáž, která jej obsahuje
|
CZ22394U1
(cs)
|
2011-03-11 |
2011-06-20 |
Contipro C, A.S. |
Antimikrobiální smes a kryt pro podporu hojení ran s antimikrobiálním úcinkem
|
EP2543357B1
(en)
|
2011-07-07 |
2018-03-21 |
Holy Stone Healthcare Co.,Ltd. |
Composition for use in treating and preventing inflammation related disorder
|
EP2545925B1
(en)
|
2011-07-12 |
2018-02-14 |
Holy Stone Healthcare Co.,Ltd. |
Compositions comprising hyaluronic acid for treating and preventing mucosa related diseases
|
ITMI20111747A1
(it)
|
2011-09-28 |
2013-03-29 |
Fidia Farmaceutici |
Composizioni farmaceutiche topiche comprendenti aciclovir
|
ITPD20120173A1
(it)
|
2012-05-31 |
2013-12-01 |
Fidia Farmaceutici |
"nuovo sistema di rilascio di proteine idrofobiche"
|
JP2014141475A
(ja)
*
|
2012-12-27 |
2014-08-07 |
Daiichi Sankyo Co Ltd |
新規美白剤
|
KR101412776B1
(ko)
|
2013-03-11 |
2014-07-01 |
가톨릭대학교 산학협력단 |
각결막염 치료용 점안제 조성물 및 이의 제조 방법
|
CN103319627A
(zh)
*
|
2013-07-10 |
2013-09-25 |
南宁中诺生物工程有限责任公司 |
一种对透明质酸钠进行分子量分级的方法
|
US9089562B2
(en)
*
|
2013-08-28 |
2015-07-28 |
Presbyopia Therapies Llc |
Compositions and methods for the treatment of presbyopia
|
JP2017505805A
(ja)
*
|
2014-02-11 |
2017-02-23 |
オラシス ファーマシューティカルズ リミティド |
老眼矯正に使用される眼科用薬理組成物及びその投与
|
EP2910255A1
(en)
*
|
2014-02-19 |
2015-08-26 |
MedSkin Solutions Dr. Suwelack AG |
Methods for the production of biopolymers with defined average molecular weight
|
US9603867B2
(en)
*
|
2015-03-03 |
2017-03-28 |
Yung Shin Pharm. Ind. Co., Ltd. |
Pharmaceutical composition for improving wound healing or prophylactically preventing or inhibiting scar formation
|
ITUB20152542A1
(it)
*
|
2015-07-28 |
2017-01-28 |
Altergon Sa |
Formulati oftalmici a base di complessi cooperativi di acido ialuronico a basso e alto peso molecolare
|
EP4166145A1
(en)
*
|
2016-02-12 |
2023-04-19 |
Laimu Corporation |
Nerve growth promoter and method for producing same, internal preparation, medium additive, cell dilution additive, medium, cell dilution, antioxidant and method for producing same, external preparation, and wound treatment agent and method for producing same
|
CN109803652A
(zh)
|
2016-08-19 |
2019-05-24 |
阿拉西斯医药公司 |
眼科药物组合物及其相关用途
|
CN106727246A
(zh)
*
|
2017-02-08 |
2017-05-31 |
上海元茵生物科技有限公司 |
小牛血清细胞营养液
|
CN107802597B
(zh)
*
|
2017-12-08 |
2020-07-31 |
北京诺康达医药科技股份有限公司 |
一种玻璃酸钠组合物及其制备方法和应用
|
MX2020007692A
(es)
*
|
2018-01-18 |
2020-09-14 |
Faes Farma Sa |
Composiciones oftalmicas que comprenden bilastina, una beta-ciclodextrina y al menos un agente de gelificacion.
|
FR3086865B1
(fr)
*
|
2018-10-04 |
2023-04-28 |
Matthieu Leconte |
Preparation ophtalmique et lentille d'orthokeratologie pour l'inhibition, la prevention et/ou la limitation de la progression de la myopie
|